Boothbay Fund Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,446	Closed	-$72.1K	–	2449
2025 Q3	$72.1K	Buy	+14,446	New	+$66.9K	﹤0.01%	1760
2024 Q4	–	Sell	-17,344	Closed	-$81.3K	–	1997
2024 Q3	$81.3K	Buy	+17,344	New	+$93K	﹤0.01%	1473
2020 Q3	–	Sell	-298,605	Closed	-$3.42M	–	1290
2020 Q2	$3.42M	Buy	298,605 +20,505	+7%	+$232K	0.29%	100
2020 Q1	$2.88M	Buy	278,100 +130,100	+88%	+$1.61M	0.29%	102
2019 Q4	$2.43M	Sell	148,000 -1,139	-0.8%	-$17.2K	0.26%	117
2019 Q3	$1.98M	Buy	149,139 +28,141	+23%	+$392K	0.24%	146
2019 Q2	$1.71M	Buy	120,998 +85,064	+237%	+$1.35M	0.2%	169
2019 Q1	$661K	Buy	35,934 +26,171	+268%	+$596K	0.09%	310
2018 Q4	$255K	Buy	+9,763	New	+$230K	0.05%	428
2018 Q2	–	Sell	-19,346	Closed	-$326K	–	972
2018 Q1	$326K	Buy	+19,346	New	+$324K	0.05%	448